OSEBX1 963,65+0,00 %
EQNR371,80+1,03 %
DNB280,60+0,97 %
MOWI205,40+1,18 %
Brent$111,49+0,99 %
Gold$4 572,10−1,24 %
USD/NOK9,2721+0,10 %
EUR/NOK10,8797+0,12 %
SPX7 209,01+0,00 %
NDX27 452,12+0,00 %
LIVE · 09:54 UTC

Kesoram Industries Ltd

KESORAMIND · Textiles, Apparel & Luxury Goods · India

Profile
TickerKESORAMIND
RICKSRM.NS
ISININE087A01019
IssuerKesoram Industries Ltd
SectorConsumer Discretionary
IndustryTextiles, Apparel & Luxury Goods
Sub-industrySpecialty Chemicals
HeadquartersKolkata, India
Country of issuerIndia
Founded1919-10-18
Employees25
Total share float131,157,431
Holders (C/S)78,383
AuditorWalker Chandiok & Co LLP
CEO / managementMr. Satish Narain Jajoo
Business Description

Kesoram Industries Limited is an India-based company. The Company's segments include rayon, transparent paper, and chemicals, and others. Its rayon business manufactures viscose rayon filament yarn and transparent paper. Its rayon is marketed under the brand name Kesoram Rayon and its transparent paper is marketed under the brand name Kesophane. It manufactures deniers of varying thickness from 75 deniers to 700 deniers. The Company's rayon and transparent paper plant is located Hooghly, West Bengal.

ESG · Risk Indicators
Controversies score
Governance pillar
Social pillar
Insider trading score
Industry Substrate · Chemicals
Signals to watch
  • Feedstock spread (price - input cost) (leading)
  • Plant utilization rate (coincident)
  • End-market demand (auto, construction, agri) (leading)
  • Inventory destocking/restocking cycles (coincident)
  • Specialty volume growth (trend)
Geopolitical drivers
  • Energy/feedstock cost (Russia gas, Middle East oil) · exposure: high
  • Trade tariffs on chemical exports/imports · exposure: medium-high
  • Environmental regulation (EU REACH, US EPA) · exposure: high
  • Agricultural policy (subsidies, fertilizer demand) · exposure: medium for agri-chem
Industry KPIs
  • EBITDA margin % — 5-15% commodity; 15-25% specialty
  • Capex/sales % — watch trough vs peak
  • Plant utilization % — 82-92% healthy; <80% pressure
  • ROIC — 10%+ specialty; 6-10% commodity through cycle
  • Net debt / EBITDA — below 3.0x healthy; cyclical buffer
Full Analysis Pending

Detailed financial analysis, valuation snapshot, multi-period history, and AI narrative are pending — generated when this company is included in the next analysis batch. Profile data above is point-in-time as of 2026-04-30.